Table 2.
SD | SD +PFOS | H-SD | H-SD +PFOS | HFD | HFD +PFOS | |
---|---|---|---|---|---|---|
| ||||||
Serum (μg/mL) | <LLOQ | 40.0 ± 6.9 | <LLOQ | 34.8 ± 6.1 ¶ | <LLOQ | 42.4 ± 2.0 |
Liver PFOS (μg PFOS/g tissue) | <LLOQ | 200.2 ± 22.5 | <LLOQ | 148.0 ± 16.1 * | <LLOQ | 137.0 ± 32.8 * |
Total Liver PFOS (μg PFOS) | 363.5 ± 20.2 | 272.7 ± 18.0 *¶ | 354.1 ± 38.4 | |||
Liver/Serum Ratio | 5.2 ± 0.33 | 4.4 ± 0.44 | 3.3 ± 0.34 * | |||
Serum PFOS (mg PFOS/mL per mg of PFOS consumed) | 2.32 ± 0.14 | 2.19 ± 0.14 ¶ | 6.01 ± 0.13 * | |||
Liver PFOS (mg PFOS/g tissue per mg of PFOS consumed) | 11.6 ± 0.5 | 9.3 ± 0.4 ¶ | 19.4 ± 2.1 * |
Male C57BL/6N mice were fed either control standard chow diet (SD) or a 60% kCal high fat diet (HFD).After 4 weeks, half of HFD mice were switched to a SD (H-SD) to induce weight loss, and mice were further divided with a subset having 0.0003% PFOS in diet. Mice were kept on study for an additional 10 weeks. PFOS was extracted from liver and serum and quantified using LC-MS/MS. All mice that were not dosed with PFOS had concentrations below the lower limit of quantification (LLOQ, 15 ng/mL, 3 μg/g tissue).Total liver PFOS was calculated by multiplying concentration by total liver weights and PFOS concentrations were also normalized to average food consumption within each diet group. The HFD and H-SD mice had a lower liver PFOS concentration, and the H-SD mice had less overall liver PFOS. The HFD mice had a higher liver and serum PFOS concentration relative to the amount of PFOS consumed within the diet. Calculations were performed using a one-way ANOVA followed by Fisher’s LSD test. All values are means ± SD; N=5–8.
indicates p<0.05 versus SD+PFOS
indicates p<0.05 for H-SD+PFOS versus HFD+PFOS.